An Experimental Sequential Digestion Method for Efficient Isolation of Human Adipose-Derived Microvascular Fragments with Enhanced Angiogenic Potential.
Yin X., Liu X., Yang J., Liu X., Ji Q., Xie Y.
Animal Study, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Aesthetic Plast Surg (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41565861
- PMCID
- PMC13035568
- DOI
- 10.1007/s00266-025-05606-0
Abstract (original English)
Microvascular fragments (MVFs) are intact vascular segments derived from adipose tissue that possess considerable potential for promoting tissue vascularization in regenerative medicine. However, conventional single-step enzymatic digestion methods often lead to incomplete adipose tissue dissociation and poor MVF quality. We developed and validated a sequential enzymatic digestion protocol optimized for isolating MVFs from human lipoaspirate. Adipose samples were processed using either a conventional one-step collagenase digestion or a three-step sequential method. MVFs were evaluated for yield, viability, structural integrity, cellular phenotype, and angiogenic function both in vitro and in vivo. Compared with the conventional approach, the sequential protocol produced a 2.2-fold increase in MVF yield and significantly reduced undigested tissue residues (p < 0.0001). MVFs isolated by the sequential protocol showed superior cell viability (93.3% vs. 75.6%), a greater proportion of long fragments, preserved endothelial and perivascular architecture, and enhanced angiogenic performance in collagen gel assays and mouse subcutaneous implantation models. This optimized sequential digestion protocol enables the efficient and producible isolation of high-quality MVFs from human adipose tissue. It holds great promise for applications in vascularized tissue engineering and regenerative
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.